Cardiovascular and kidney outcomes and mortality with long-acting injectable and oral glucagon-like peptide 1 receptor agonists in individuals with type 2 diabetes: a systematic review and meta-analysis of randomized trials
Lee MMY, Sattar N, Pop-Busui R, et al.
Diabetes Care. 2025:dc250241.
Leggi